Aldeyra Therapeu (ALDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 8,001 | 10,169 | 10,428 | 16,578 | 16,138 |
| Operating Income | -8,001 | -10,169 | -10,428 | -16,578 | -16,138 |
| Interest Expense | 476 | 471 | 484 | 471 | 479 |
| Other Income | 789 | 872 | 982 | 1,240 | 1,504 |
| Pre-tax Income | -7,688 | -9,767 | -9,930 | -15,809 | -15,113 |
| Net Income Continuous | -7,688 | -9,767 | -9,930 | -15,809 | -15,113 |
| Net Income | $-7,688 | $-9,767 | $-9,930 | $-15,809 | $-15,113 |
| EPS Basic Total Ops | -0.13 | -0.16 | -0.17 | -0.27 | -0.25 |
| EPS Basic Continuous Ops | -0.13 | -0.16 | -0.17 | -0.27 | -0.25 |
| EPS Diluted Total Ops | -0.13 | -0.16 | -0.17 | -0.27 | -0.25 |
| EPS Diluted Continuous Ops | -0.13 | -0.16 | -0.17 | -0.27 | -0.25 |
| EPS Diluted Before Non-Recurring Items | -0.13 | -0.16 | -0.17 | -0.27 | -0.25 |
| EBITDA(a) | $-8,204 | $-10,536 | $-10,776 | $-16,979 | $-16,583 |